Wikidata

(Q33195217)

English

European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme.

scientific article

In more languages

Statements

title
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
14630677
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630677%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33195217&oldid=2050017295"